Comparison of [18F]-fluorodeoxyglucose positron emission tomography and technetium bisphosphonate bone scintigraphy to detect bone metastases in patients with breast cancer;Comparaison de la tomographie par émission de positons au [18F]-fluorodésoxyglucose et de la scintigraphie du squelette aux bisphosphonates technétiés pour la détection des métastases osseuses dans le cancer du sein

Medecine Nucleaire

Volumn 28, Issue 7, 2004, Pages 297-303

  Raileanu, I ^a   Grahek, D ^a   Montravers, F ^a   Kerrou, K ^a   Aide, N ^a   Younsi, N ^a   Talbot, J N ^a  

^a HÔPITAL TENON   (France)

Author keywords

18F FDG PET; Bone metastasis; Bone scintigraphy; Breast cancer; Conventional imaging

Indexed keywords

FLUCIS; FLUORODEOXYGLUCOSE F 18; OXIDRONATE TECHNETIUM TC 99M;

ADULT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 4644225044     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., Feuer E.J., Thun M.J. American Cancer Society Cancer statistics 2004. CA Cancer J Clin 2004; 54 (1): 8-29.
2. Czernin J. FDG-PET in breast cancer: a different view of its clinical usefulness. Mol Imaging Biol 2002; 4 (1): 35-45.
3. Durand M., Mauriac L. Métastases vertébrales des cancers du sein. In: Pointillart V., Ravaud A., Palussiere J., eds. Métastases vertébrales. Springer-Verlag, France 2001; 60-84.
4. O'Sullivan J.M., Cook G.J. A review of the efficacy of bone scanning in prostate and breast cancer. Q J Nucl Med 2002; 46 (2): 152-159.
5. Ali S.M., Harvey H.A., Lipton A. Metastatic breast cancer. Clinical orthopaedics and related research 2003; S132-S137.
6. 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998; 16 (10): 3375-3379.
7. Roodman D.G. Mechanisms of bone metastasis. N Engl J Med 2004; 350 (16): 1655-1664.
8. Schirrmeister H., Kuhn T., Guhlmann A., Santjohanser C., Horster T., Nussle K., Koretz K., Glatting G. Rieber A., Kreienberg R., Buck A.C., Reske S.N. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001; 28 (3): 351-358.
9. Coleman R.E., Rubens R.D., Fogelman I. Reappraisal of the baseline bone scan in breast cancer. J Nucl Med 1988; 29 (6): 1045-1049.
10. Pointillart V., Ravaud A., Palussiere J. Imagerie des métastases vertébrales. In: Pointillart V., Ravaud A., Palussiere J., eds. Métastases vertébrales. Springer-Verlag, France 2001; 60-84.
11. 99mTc-MDP bone scintigraphy. Nucl Med Commun 2001; 22 (8): 875-879.
12. Dose J., Bleckmann C., Bachmann S., Bohuslavizki K.H., Berger J., Jenicke L., Habermann C.R., Janicke F. Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients. Nucl Med Commun 2002; (9): 857-864.
13. Yang S.N., Liang J.A., Lin EJ., Kao C.H., Lin C.C., Lee C.C. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m diphosphonate bone scan to detect bone metastases in patients with breast cancer. J Cancer Res Clin Oncol 2002; 128: 325-328.
14. Kato K., Aoki J., Endo K. Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase. Ann Nucl Med 2003; 17 (1): 41-46.
15. Metser U., Lerman H., Blank A., Lievshitz G., Bokstein F., Even-Sapir E. Malignant involvement of the spine: assessment by 18F-FDG-PET/CT. J Nucl Med 2004; 45 (2): 279-284.
16. Nakamoto Y., Osman M., Wahl R.L. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG. Clin Nucl Med 2003; 28 (4): 302-307.
17. Bohdiewicz P.J., Wong C. Y., Kondas D., Gaskill M., Dworkin H.J. High predictive value of F-18 FDG-PET patterns of the spine for metastases or benign lesions with good agreement between readers. Clin Nucl Med 2003; 28 (12): 966-970.